The Spdr S&p Biotech (NYSE: XBI) report below can help you, but we have more details too. The trading plans for XBI, and the other 1000+ stocks we follow, are updated in real time for subscribers, but this report is static. If you want an update, or a different report, please get one here Unlimited Real Time Reports .
Technical Summary
Term ? | Near | Mid | Long |
---|---|---|---|
Bias | Neutral | Neutral | Strong |
P1 | 0 | 0 | 102.00 |
P2 | 114.43 | 112.84 | 114.91 |
P3 | 116.61 | 116.17 | 126.22 |
Long Term Trading Plans for XBI
October 28, 2020, 11:00 pm ET
The Technical Summary and Trading Plans for XBI help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this XBI Report.
XBI - (Long) Support Plan
The technical summary data tells us to buy XBI near 102.00 with an upside target of 114.91. This data also tells us to set a stop loss @ 101.71 to protect against excessive loss in case the stock begins to move against the trade. 102.00 is the first level of support below 114.2 , and by rule, any test of support is a buy signal. In this case, support 102.00 would be being tested, so a buy signal would exist.
XBI - (Short) Resistance Plan
The technical summary data is suggesting a short of XBI as it gets near 114.91 with a downside target of 102.00. We should have a stop loss in place at 115.24 though. 114.91 is the first level of resistance above 114.2, and by rule, any test of resistance is a short signal. In this case, if resistance 114.91 is being tested, so a short signal would exist.